CompuGroup Medical Acquires VISUS Health IT

CompuGroup Medical SECompuGroup Medical SE & Co. KGaA (CGM), one of the leading e-health companies in the world, acquired VISUS Health IT GmbH (VISUS), one of the leading providers for Picture Archiving and Communication Systems (PACS) and Healthcare Content Management in Germany.

VISUS's key products are JiveX Enterprise PACS, a leading PACS for hospitals and outpatient facilities, JiveX Healthcare Content Management, a cutting-edge vendor neutral archive solution for medical data, and JiveX Healthcare Connect with focus on communicating medical data. As a result of the acquisition, CompuGroup Medical is complementing its portfolio with a well-established and multiple award-winning product suite. For 2020, revenues were amounted to approximately EUR 18.5 million with an adjusted EBITDA of approximately EUR 2.8 million.

"VISUS complements our existing portfolio of products perfectly and we see a lot of opportunities to integrate these solutions with our successful ambulatory and hospital information systems," emphasized Dr. Dirk Wössner, CEO of CompuGroup Medical SE & Co. KGaA. "We are confident that both, existing CGM and VISUS customers, will benefit from this transaction, facilitating the provision of structured medical data at the right place and time and usable by anyone who needs it. VISUS solutions are a key contributor of medical information with the special focus on medical images."

"With this acquisition, we will gain an additional, highly attractive business area, which is very important for most of our customers, and we will significantly increase our installed customer base particularly in the German hospital market. At the same time, we will benefit from a great amount of know-how and expert knowledge from our new colleagues. We are acquiring innovative and strongly growing products here, which have recently been repeatedly honored with several highly prestigious 'Best in KLAS-Awards'," said Hannes Reichl, Managing Director Inpatient and Social Care at CGM.

"We are convinced that with this merger we will continue the success story of VISUS for our team and our customers in the long term. With CGM, we also have the potential to further expand our existing partner network internationally," said Klaus Kleber, Co-Founder of VISUS. Jörg Holstein, likewise Co-Founder of VISUS, added, "We have been partners with CGM for many years and have implemented many successful projects together. We are pleased to become part of the CGM family while maintaining the VISUS identity. CGM is exactly the right partner for us as a global player with home and heart in Germany."

VISUS's customer base today consists of more than 1.500 facilities inpatient as well as outpatient. Today, more than 1.6 million professional users, including doctors, dentists, pharmacies and other health professionals in outpatient and inpatient healthcare facilities trust CompuGroup Medical.

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 837 million in 2020, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. Approximately 8,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...